Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 2/20 | 0.33 |
| ▸ | CTSB | P07858 | 2/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21775400 | 0.78 | — | — | |
| SCHEMBL21784427 | 0.75 | CTSK (0.38) | CTSKCTSLCTSBCTSDCTSS | |
| SCHEMBL29460254 | 0.73 | CTSK (0.42) | CTSKCA12CA14CA1CA7 | |
| SCHEMBL344121 | 0.72 | USP2 (0.41) | CTSK | |
| SCHEMBL583414 | 0.71 | CA12 (0.42) | CTSKCA12CA14CA1CA7 | |
| SCHEMBL12792779 | 0.71 | CA12 (0.42) | CTSKCA12CA14CA1CA7 | |
| SCHEMBL29460248 | 0.71 | CTSK (0.43) | CTSKCA12CA14CA1CA7 | |
| SCHEMBL8276176 | 0.70 | CA12 (0.41) | CA12CA14CA1CA7CA2 | |
| SCHEMBL12421750 | 0.70 | CA12 (0.45) | CTSKCA12CA14CA1CA7 | |
| SCHEMBL24643192 | 0.70 | CTSK (0.54) | CTSKCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512064-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2022-11-29 | — | — | US | disclosed |
| US-20210300891-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2021-09-30 | — | — | US | disclosed |
| US-20210300891-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2021-09-30 | — | — | US | disclosed |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | WILMINGTON PHARMATECH | 2020-03-05 | — | — | US | disclosed |
| WO-2020047198-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION (US) | 2020-03-05 | — | — | WO | disclosed |
| WO-2020047198-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION (US) | 2020-03-05 | — | — | WO | disclosed |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | WILMINGTON PHARMATECH | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512064-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | KDM1A, KDM1B, KDM2A | CTSK 3644/4885CA12 2498/4885CA14 3083/4885 |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | KDM1A, KDM1B, KDM2A | CTSK 3644/4885CA12 2498/4885CA14 3083/4885 |
| US-20210300891-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | KDM1A, KDM1B, KDM2A | CTSK 3644/4885CA12 2498/4885CA14 3083/4885 |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | KDM1A, KDM1B, KDM2A | CTSK 3644/4885CA12 2498/4885CA14 3083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.